Clinical Trial Update: Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments [Phase 1]

View source ↗

Summary

Phase 1 study evaluating CS-1008 in combination with FOLFIRI for metastatic colorectal cancer has been completed, assessing safety and preliminary efficacy in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CS-1008
• Irinotecan (Camptosar) (Irinotecan)
• Leucovorin (folinic acid) (folinic acid)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: COMPLETED